| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8531601 | International Immunopharmacology | 2018 | 7 Pages |
Abstract
Anti-TNF drugs disinhibit B cell production in IBD patients, but maintain the constant homeostasis of circulating B cells. The presence of individual variations may allow the activity of anti-TNF drugs to be monitored by studying B cell subgroups.
Keywords
IPCPerCP-Cy5.5PPBSPTPN2IFNγT-helperMBSHBSPBSAPCIBDFITCmAbsAPEallophycocyaninantigen-presenting cellinterferon-gammaCrohn's diseaseInflammatory bowel diseasePCsplasma cellsMemory B cellsphycoerythrinfluorescein isothiocyanatePhosphate-buffered salinegerminal centrebone marrowHematogonesMonoclonal antibodiesPlasmablastsUlcerative colitis
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Caterina Defendenti, Fabiola Atzeni, Sergio Malandrin, Sandro Ardizzone, Piero Luigi Almasio, Simone Saibeni, Cristina Bezzio, Simona Bollani, Raffaele Salerno, Paolo Declich, Zoe Sarno, Savino Bruno, Rossella Talotta, Piercarlo Sarzi-Puttini,